Skip Navigation

Fertility Preservation

Skip sharing on social media links

This Program, directed by Dr. Charisee Lamar, supports basic, clinical, and translational research that is designed to preserve reproductive capacity in individuals who are or may become infertile secondary to chronic disease (e.g., cancer, systemic lupus erythematosus, uterine fibroids, endometriosis, polycystic ovarian syndrome) or disease treatment (radiation, chemotherapy, or surgery), exposure to environmental toxicants, advanced reproductive age, or genetic predisposition. Specifically, the Fertility Preservation Program encourages applications in the following priority areas: epidemiologic studies designed to determine the incidence and prevalence of infertility in individuals who have been exposed to life-saving, but gonadotoxic chemo- or radiation therapy in children, reproductive-age women and men; applications that propose to develop biomarkers and clinical parameters to better predict gonadal reserve; studies that propose to elucidate the mechanism(s) in which chemo- and radiation therapy negatively impact fertility status; and technology proposals that have the potential to optimize or expand options for fertility preservation.

Last Reviewed: 09/15/2014
Vision National Institutes of Health Home BOND National Institues of Health Home Home Storz Lab: Section on Environmental Gene Regulation Home Machner Lab: Unit on Microbial Pathogenesis Home Division of Intramural Population Health Research Home Bonifacino Lab: Section on Intracellular Protein Trafficking Home Lilly Lab: Section on Gamete Development Home Lippincott-Schwartz Lab: Section on Organelle Biology